Wesana Health Holdings Inc. (WSNAF)
WSNAF Stock Price Chart
Explore Wesana Health Holdings Inc. interactive price chart. Choose custom timeframes to analyze WSNAF price movements and trends.
WSNAF Company Profile
Discover essential business fundamentals and corporate details for Wesana Health Holdings Inc. (WSNAF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Jun 2021
Employees
7.00
Website
https://www.wesanahealth.comCEO
Daniel Carcillo
Description
Wesana Health Holdings Inc, a life sciences company, engages in the development and delivery of psychedelic medicines and psilocybin-assisted psychotherapies to treat traumatic brain injuries. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is based in Chicago, Illinois.
WSNAF Financial Timeline
Browse a chronological timeline of Wesana Health Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 6 May 2025
Earnings released on 30 Sept 2024
EPS came in at -$0.00 .
Earnings released on 29 Jun 2024
EPS came in at -$0.01 .
Earnings released on 30 Mar 2024
EPS came in at -$0.01 surpassing the estimated -$0.06 by +89.97%.
Earnings released on 30 Dec 2023
EPS came in at -$0.04 surpassing the estimated -$0.06 by +41.03%.
Earnings released on 30 Sept 2023
EPS came in at $0.02 surpassing the estimated -$0.05 by +135.78%.
Earnings released on 29 Jun 2023
EPS came in at -$0.03 surpassing the estimated -$0.04 by +32.55%.
Earnings released on 30 Mar 2023
EPS came in at -$0.02 surpassing the estimated -$0.02 by +6.55%.
Earnings released on 31 Dec 2022
EPS came in at -$0.06 falling short of the estimated -$0.04 by -55.83%.
Earnings released on 30 Nov 2022
EPS came in at $0.01 surpassing the estimated -$0.07 by +114.29%.
Earnings released on 28 Aug 2022
EPS came in at -$0.07 surpassing the estimated -$0.10 by +30.00%, while revenue for the quarter reached $1.92K , missing expectations by -99.43%.
Earnings released on 31 May 2022
EPS came in at -$0.15 surpassing the estimated -$0.16 by +6.25%, while revenue for the quarter reached $242.11K , missing expectations by -7.94%.
Earnings released on 1 May 2022
EPS came in at -$1.17 falling short of the estimated -$0.12 by -877.19%, while revenue for the quarter reached $221.82K , missing expectations by -4.80%.
Earnings released on 31 Dec 2021
EPS came in at -$0.37 , while revenue for the quarter reached $267.21K .
Earnings released on 29 Nov 2021
EPS came in at -$0.29 , while revenue for the quarter reached $42.86K .
Earnings released on 30 Aug 2021
EPS came in at -$0.42 .
Earnings released on 31 May 2021
Stock split effective on 10 May 2021
Shares were split 7 : 200 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2020
EPS came in at -$0.00 , while revenue for the quarter reached $19.23K .
WSNAF Stock Performance
Access detailed WSNAF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.